Summary
This consultation seeks views on proposals to update the
statutory scheme to control the cost of branded health service
medicines.
This consultation closes at
11:59pm on 26 April 2024
Consultation description
The statutory scheme is set out in legislation in The Branded
Health Service Medicines (Costs) Regulations 2018. It is one
of 2 schemes, alongside the 2024 voluntary scheme for branded
medicines pricing, access and growth (VPAG),
that control the costs of branded medicines to the NHS.
VPAG was agreed in late 2023 and replaced the 2019
voluntary scheme for branded medicines pricing and access from 1
January 2024.
The government is proposing updates to the statutory scheme to
maintain broad commercial equivalence with
VPAG. The consultation proposes to introduce
a differentiated approach to setting payment percentages for
newer medicines and older medicines, and includes proposals on:
-
defining older and newer medicines
-
setting the headline payment percentage for newer medicines
-
setting the basic payment percentage and top-up payment
percentage for older medicines
-
calculating the price decline of older medicines
The consultation also proposes increasing the threshold for an
exemption from scheme payments for small companies.
Documents
Proposed update to the
statutory scheme to control the cost of branded health service
medicines
Impact assessment:
proposed update to the statutory scheme to control the cost of
branded health service medicines
Ways to respond
Respond online
